Tezepelumab in Chronic Rhinosinusitis with Nasal Polyps: Pathophysiology, Clinical Evidence, and Therapeutic Perspectives.

Aigozhina B, Tulebaeyv R, Azhenov T, Dzhandayev S, Papulova N, Zhankina R, Sagandykova K

Open source

DOI
10.3390/medicina62071423
Published
2026 Jul 22
Container
Medicina (Kaunas, Lithuania)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/medicina62071423,
  title = {Tezepelumab in Chronic Rhinosinusitis with Nasal Polyps: Pathophysiology, Clinical Evidence, and Therapeutic Perspectives.},
  author = {Aigozhina B and Tulebaeyv R and Azhenov T and Dzhandayev S and Papulova N and Zhankina R and Sagandykova K},
  year = {2026},
  journal = {Medicina (Kaunas, Lithuania)},
  doi = {10.3390/medicina62071423},
  url = {https://doi.org/10.3390/medicina62071423}
}

RIS

TY  - JOUR
TI  - Tezepelumab in Chronic Rhinosinusitis with Nasal Polyps: Pathophysiology, Clinical Evidence, and Therapeutic Perspectives.
AU  - Aigozhina B
AU  - Tulebaeyv R
AU  - Azhenov T
AU  - Dzhandayev S
AU  - Papulova N
AU  - Zhankina R
AU  - Sagandykova K
PY  - 2026
JO  - Medicina (Kaunas, Lithuania)
DO  - 10.3390/medicina62071423
UR  - https://doi.org/10.3390/medicina62071423
ER  - 

APA

B, A., R, T., T, A., S, D., N, P., R, Z., & K, S. (2026). Tezepelumab in Chronic Rhinosinusitis with Nasal Polyps: Pathophysiology, Clinical Evidence, and Therapeutic Perspectives.. Medicina (Kaunas, Lithuania). https://doi.org/10.3390/medicina62071423

Source records